A Phase 2 Study of Efficacy and Safety of AK111 in Subjects With Moderate-to-Severe Psoriasis
Clinical trial NCT05096364 · COMPLETED
Trial details
- NCT number
- NCT05096364
- Sponsor
- Akeso
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-28
- Primary completion
- 2023-02-03
- Enrollment
- 251
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.